|
Volumn 48, Issue 12, 2000, Pages 873-876
|
Role of chemotherapy in curative treatment of head and neck tumours;Bedeutung der chemotherapie in der kurativen therapie von kopf-hals-tumoren
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CETUXIMAB;
CISPLATIN;
DOCETAXEL;
EPIDERMAL GROWTH FACTOR RECEPTOR;
FLUOROURACIL;
GEFITINIB;
ONYXVIRUS;
PROTEIN P53;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
VASCULOTROPIN;
VASCULOTROPIN RECEPTOR;
CANCER ADJUVANT THERAPY;
CANCER COMBINATION CHEMOTHERAPY;
HEAD AND NECK CARCINOMA;
HUMAN;
META ANALYSIS;
PROGNOSIS;
REVIEW;
TUMOR LOCALIZATION;
TUMOR SUPPRESSOR GENE;
COMBINED MODALITY THERAPY;
HUMANS;
NEOPLASM STAGING;
OTORHINOLARYNGOLOGIC NEOPLASMS;
RADIOTHERAPY, ADJUVANT;
RANDOMIZED CONTROLLED TRIALS;
SURVIVAL RATE;
|
EID: 0034521539
PISSN: 00176192
EISSN: None
Source Type: Journal
DOI: 10.1007/s001060050682 Document Type: Review |
Times cited : (1)
|
References (8)
|